The lancet oncology
-
The lancet oncology · Dec 2017
Cancer incidence and mortality among young adults aged 20-39 years worldwide in 2012: a population-based study.
To date, the burden of cancer among young adults has rarely been studied in depth. Our aim was to describe the scale and profile of cancer incidence and mortality worldwide among 20-39 year-olds, highlighting major patterns by age, sex, development level, and geographical region. ⋯ International Agency for Research on Cancer (IARC) and European Commission's FP-7 Marie Curie Actions-People-COFUND.
-
The lancet oncology · Dec 2017
Comparative StudyBiomarkers for subtypes of pancreatic ductal adenocarcinoma.
-
The lancet oncology · Dec 2017
Randomized Controlled Trial Multicenter Study Comparative StudyAdjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial.
Adjuvant chemotherapy for resected early-stage non-small-cell lung cancer (NSCLC) provides a modest survival benefit. Bevacizumab, a monoclonal antibody directed against VEGF, improves outcomes when added to platinum-based chemotherapy in advanced-stage non-squamous NSCLC. We aimed to evaluate the addition of bevacizumab to adjuvant chemotherapy in early-stage resected NSCLC. ⋯ National Cancer Institute of the National Institutes of Health.